Related by context. Frequent words. (Click for all words.) 58 mcg kg 56 FEV1 56 placebo p 55 mg BID 55 Secondary endpoints included 55 secondary endpoint 54 p = #.# [004] 53 Secondary endpoints 53 treatment emergent adverse 53 p = #.# [002] 53 IU mL 53 fasting plasma glucose 53 sustained virologic response 52 laboratory abnormalities 52 placebo p = 52 primary efficacy endpoint 52 statistically significant p 52 elagolix 52 copies mL 52 n = 52 ACR# [002] 52 peginterferon alfa 2a 51 events AEs 51 log# 51 creatinine clearance 51 P = .# 51 secondary endpoints 50 confidence interval CI 50 HCV RNA 50 Secondary endpoints include 50 primary endpoint 50 evaluable patients 50 demonstrated statistically significant 49 HbA1c levels 49 plus ribavirin 49 HbA1c 49 p = 49 statistically significant improvement 49 non inferiority 49 % CI #.#-#.# [006] 49 median PFS 49 lacosamide 49 placebo 49 FOLFOX 49 nasopharyngitis 49 mg dose 49 dyspnea 48 discontinuations due 48 mg d 48 mcg 48 bosentan 48 LVEF 48 evaluable 48 mg dL 48 mg/m2 48 certolizumab pegol 47 XGEVA 47 peginterferon 47 tiotropium 47 RECIST criteria 47 mm Hg 47 mg kg 47 statistically significant reduction 47 lopinavir ritonavir 47 ≥ 47 preoperatively 47 undetectable viral load 47 mmol L 47 Adverse events 47 adalimumab 46 postoperatively 46 quetiapine 46 mmHg 46 subscales 46 events SAEs 46 symptom severity 46 free survival PFS 46 peripheral edema 46 arthralgia 46 primary endpoints 46 preoperative 45 randomized #:# 45 composite endpoint 45 msec 45 % CI #.#-#.# [002] 45 belimumab 45 CI = 45 PASI 45 microalbuminuria 45 mL min 45 RECIST 44 HCV infected 44 achieve statistical significance 44 febrile neutropenia 44 TIMI 44 Endpoints 44 pramipexole 44 pegylated interferon 44 eGFR 44 pharmacodynamic 44 clinical endpoints